Fondazione Telethon is pleased to announce its role as the organization responsible for managing the ERDERA Clinical Trial Call 2026.
The call aims to fund Phase I, Phase I/II, and Phase II interventional clinical trials of medicinal products to generate robust clinical evidence and accelerate the development of new therapies for patients with rare diseases.
Projects must involve partners from at least three eligible countries and include meaningful patient involvement throughout the trial. Applications are open to universities, research institutes, hospitals, non-profit organizations, patient advocacy groups, and SMEs.
The application process starts with a mandatory Expression of Interest phase, open from July 1st to September 10th 2026. Submission of an EOI is mandatory for any applicant intending to submit a Short Proposal at Stage 1.
The call text and all relevant supporting documents are available below and can be downloaded using the links provided. Please check the ERDERA website for info related to the call at the following link
For scientific questions, please contact the Clinical Trial Call Scientific Secretariat at: [email protected].
| Call TIMELINE | Activity | Indicative Date |
|---|---|---|
| Stage 0 | Expression of Interest (EOI) submission deadline | September 10th, 2026 |
| Stage 1 | Short Proposal submission deadline | October 29th, 2026 |
| Stage 1 | Notification of results: invitation to Stage 2 | January 2027 |
| Stage 2 | Support phase | January – July 2027 |
| Stage 3 | Full Proposal submission period | August - September 2027 |
| Stage 3 | Formal check, scientific evaluation, rebuttal, Sponsor interview | October – December 2027 |
| Stage 3 | Notification of funding decisions | February 2028 |
The full text of the Call, together with all relevant documents, is available and can be downloaded by clicking the links below.
Clinical Trial Call 2026 Call_text [V3.0]
Annex IV. Guidelines for Canadian Applicants_VF
Clinical Trial Call 2026 EOI Guidelines
Clinical Trial Call 2026 EOI Template form
Privacy Notice Clinical Trial Call 2026 EOI
